Encouraging Efficacy And Safety: Cstone Presents Latest Clinical Data On CS5001 For Advanced Lymphoma At The 66Th ASH Annual Meeting
Encouraging Efficacy And Safety: Cstone Presents Latest Clinical Data On CS5001 For Advanced Lymphoma At The 66Th ASH Annual Meeting . (MENAFN - PR Newswire) 
  
  
 
 
 
 
 
   
  CS5001 is so far the first anti-ROR1ADC known to show clinical anti-tumor activity in both solid tumors and lymphomas. The data presented at ASH ...
América - MenaFN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108969223/Encouraging-Efficacy-And-Safety-Cstone-Presents-Latest-Clinical-Data-On-CS5001-For-Advanced-Lymphoma-At-The-66Th-ASH-Annual-Meeting
2024-12-08
rss
(MENAFN - PR Newswire) 
  
  
 
 
 
 
 
   
  CS5001 is so far the first anti-ROR1ADC known to show clinical anti-tumor activity in both solid tumors and lymphomas. The data presented at ASH ...
Encouraging Efficacy And Safety: Cstone Presents Latest Clinical Data On CS5001 For Advanced Lymphoma At The 66Th ASH Annual Meeting